Skip to main content
. 2026 Sep 21;31(18):3349. doi: 10.3390/molecules31183349
1D One-Dimensional
2D Two-Dimensional
4-HPAA 4-Hydroxyphenylacetate
Ace Acetone
ACEi Angiotensin-Converting Enzyme inhibitors
ACE-R Revised Addenbrooke’s Cognitive Test
AChE Acetylcholinesterase
AnCoa Anticoagulants
ARA Angiotensin II Receptor Antagonists
AUC Area Under the Curve
AUROC Area Under the Receiver Operating Characteristic Curve
BAA Beta-Adrenergic Antagonists
BMI Body Mass Index
BP Blood Pressure
CCB Calcium Channel Blockers
Cit Citrate
CST Chi-Squared Test
CVMD Cardiovascular or Metabolic Diseases
DBP Diastolic Blood Pressure
DIU Diuretics
DPP-4 Dipeptidyl peptidase-4
EBIcohort Elders from Beira Interior cohort
FET Fisher’s Exact Test
GDS Global Deterioration Scale
HDL cholesterol High-Density Lipoprotein cholesterol
HT Hypertension
HTall Group consisting of participants diagnosed with hypertension (with and without comorbidities)
HTo Subgroup (inside HTall group) of participants diagnosed with hypertension, without any cardiovascular or metabolic comorbidities.
HTdl Subgroup of participants diagnosed with hypertension + dyslipidemia, without other cardiovascular or metabolic comorbidities (namely, diabetes or cardiovascular diseases)
HTdb Subgroup of participants diagnosed with hypertension + diabetes, without other cardiovascular or metabolic comorbidities (namely, dyslipidemia or cardiovascular diseases)
HTcd Subgroup of participants diagnosed with hypertension + one cardiovascular disease (heart failure, arrhythmia, or history of acute myocardial infarction), without other cardiovascular or metabolic comorbidities (namely dyslipidemia or diabetes)
HTdb•dl Subgroup of participants diagnosed with hypertension + dyslipidemia + diabetes, without other cardiovascular or metabolic comorbidities (namely, cardiovascular diseases)
HTcd•dl Subgroup of participants diagnosed with hypertension + dyslipidemia + one cardiovascular disease (heart failure, arrhythmia, or history of acute myocardial infarction), without other cardiovascular or metabolic comorbidities (namely, diabetes)
HTcd•db Subgroup of participants diagnosed with hypertension + diabetes + one cardiovascular disease (heart failure, arrhythmia, or history of acute myocardial infarction), without other cardiovascular or metabolic comorbidities (namely, dyslipidemia)
JRES J-RESolved spectroscopy
KWT Kruskal–Wallis test
LDL cholesterol Low-Density Lipoprotein cholesterol
LTCF Long-Term Care Facilities
MAO Monoamine oxidase
MG Methylglutaconate
MMSE Mini-Mental State Examination
MWT Mann–Whitney Test
N-IVG N-Isovaleroylglycine
NMDA N-Methyl-D-Aspartate
NMR Nuclear Magnetic Resonance
NOESY Nuclear Overhauser Effect Spectroscopy
NT Normotensive
OWAT One-way ANOVA test
Oxa Oxaloacetate
Phe Phenylalanine
Pyr Pyridoxate
S.E. Standard Error
Sar Sarcosine
SBP Systolic Blood Pressure
STT Student t-test
TOCSY Total Correlation Spectroscopy
WHO World Health Organization